40岁以下青年人膀胱癌的临床特征及预后

陈晓榕; 王海峰; 左毅刚

doi:10.13201/j.issn.1001-1420.2019.12.019

40岁以下青年人膀胱癌的临床特征及预后

- 昆明医科大学第二附属医院泌尿外科云南省泌尿外科研究所(昆明, 650101)
基金项目:
国家自然科学基金资助（编号81660422、81460384）

详细信息

通讯作者: 左毅刚,E-mail:yszyg924@sina.com

中图分类号: R737.14

收稿日期: 2019-03-26

Clinical features and prognosis of bladder cancer in young people under 40 years old

- Department of Urology, Second Affiliated Hospital of Kunming Medical University, Yunnan Institute of Urology, Kunming, 650101, China

More Information

Corresponding author: ZUO Yigang, E-mail: yszyg924@sina.com

Received Date: 26 March 2019

摘要

摘要: 40岁以下青年人群膀胱癌发病率呈增长趋势，最常见的临床表现为无痛性肉眼血尿，低级别尿路上皮癌为主要病理类型。已有大量研究表明青年人膀胱癌相对于年长者进展率、复发率较低，但其预后是否比年长者更好尚无定论。本文以40岁以下膀胱癌患者为目标人群，从症状、病因、病理类型、治疗、预后等方面作一综述，为青年人膀胱癌的早期诊断、治疗提供理论支持
- 40岁以下 /
- 膀胱癌 /
- 临床特征 /
- 预后
Abstract: The incidence of bladder cancer in young people under the age of 40 is on the rise. The most common clinical manifestation is painless macroscopic hematuria, and the primary pathological type is low-grade urothelial carcinoma. A large number of studies have shown that the rate of progression and recurrence of bladder cancer in young people is lower than that in elderly people, but whether the prognosis of bladder cancer in young people is better than that in elderly people is yet to be determined.This article mainly discusses the prognosis of young patients with bladder cancer from the aspects of clinical characteristics, treatment methods and follow-up.
- under 40 years old /
- bladder cancer /
- clinical features /
- prognosis

HTML全文

参考文献(34)

[1]	Siegel R L, Miller K D, Jemal A.Cancer statistics, 2019[J].CA Cancer J Clin, 2019, 69(1):7-34.
[2]	Sen V, Bozkurt O, Demir O, et al.Clinical Behavior of Bladder Urothelial Carcinoma in Young Patients:A Single Center Experience[J].Scientifica(Cairo), 2016, 2016:6792484.
[3]	Paner G P, Zehnder P, Amin A M, et al.Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients:a comprehensive review of literature with implications for patient management[J].Adv Anat Pathol, 2011, 18(1):79-89.
[4]	Stanton M L, Xiao L, Czerniak B A, et al.Urothelial tumors of the urinary bladder in young patients:a clinicopathologic study of 59 cases[J].Arch Pathol Lab Med, 2013, 137(10):1337-1341.
[5]	余凯远, 祁旦巳, 陈映鹤, 等.青年人膀胱肿瘤临床病理特点及预后[J].中国中西医结合外科杂志, 2012, 18(4):398-401.
[6]	田晶, 韩瑞发, 史启铎.40岁以下膀胱癌92例分析[J].中华泌尿外科杂志, 2006, 27(6):404-407.
[7]	Shi B, Zhang K, Zhang J, et al.Relationship between patient age and superficial transitional cell carcinoma characteristics[J].Urology, 2008, 71(6):1186-1190.
[8]	Telli O, Sarici H, Ozgur B C, et al.Urothelial cancer of bladder in young versus older adults:clinical and pathological characteristics and outcomes[J].Kaohsiung J Med Sci, 2014, 30(9):466-470.
[9]	Freedman N D, Silverman D T, Hollenbeck A R, et al.Association between smoking and risk of bladder cancer among men and women[J].JAMA, 2011, 306(7):737-745.
[10]	Otunctemur A, Koklu I, Ozbek E, et al.Are bladder neoplasms more aggresive in patients with a smoking-related second malignancy?[J].Asian Pac J Cancer Prev, 2014, 15(9):4025-4028.
[11]	Zangari A, Zaini J, Gulìa C.Genetics of Bladder Malignant Tumors in Childhood[J].Curr Genomics, 2016, 17(1):14-32.
[12]	Di Carlo D, FerrariA, Perruccio K, et al.Management and follow-up of urothelial neoplasms of the bladder in children:a report from the TREP project[J].Pediatr Blood Cancer, 2015, 62(6):1000-1003.
[13]	Aguiar L, Danialan R, Kim C.A case of high-grade transitional cell carcinoma of the bladder in a pediatric patient with Turner syndrome[J].Urology, 2015, 85(6):1477-1479.
[14]	Ribeiro J G, Klojda C A, Araújo C P, et al.Giant Leiomyosarcoma of the Urinary Bladder[J].J ClinDiagn Res, 2016, 10(5):PD14-PD15.
[15]	McGrath M, Michaud D S, De Vivo I.Hormonal and reproductive factors and the risk of bladder cancer in women[J].Am J Epidemiol, 2006, 163(3):236-344.
[16]	舒筠然, 陈晶, 钱佳丽, 等.雌激素、孕激素及其受体与膀胱癌关系的研究进展[J].临床泌尿外科杂志, 2018, 33(11):925-928.
[17]	Lee S B, KimH S, Kim M, et al.External validation of a clinical scoring system for hematuria[J].Asian Pac J Cancer Prev, 2014, 15(16):6819-6822.
[18]	Kotb A F, Attia D.High-grade microscopic hematuria in adult men can predict urothelial malignancy[J].Can Urol Assoc J, 2014, 8(7-8):E481-484.
[19]	Alanee S, Shukla A R.Bladder malignancies in children aged <18 years:results from the Surveillance, Epidemiology and End Results database[J].BJU Int, 2010, 106(4):557-560.
[20]	Saltsman J A, Malek M M, Reuter V E, et al.Urothelial neoplasms in pediatric and young adult patients:A large single-center series[J].J Pediatr Surg, 2018, 53(2):306-309.
[21]	梁恩利, 吴长利, 胡海龙, 等.30岁以下青少年膀胱尿路上皮细胞癌的临床分析[J].临床泌尿外科杂志, 2015, 30(8):715-716, 725.
[22]	Mahmoudreza K, Hassan A.P53 overexpression in bladder urothelial neoplasms new aspect of World Health Organization/International Society of Urological Pathology Classification[J].Urol J, 2007, 4(4):230-233.
[23]	Aykan S, Yuruk E, Tuken M, et al.Rare but Lethal Disease of Childhood:Metastatic, Muscle Invasive Bladder Cancer[J].Pediatr Rep, 2015, 7(3):5928.
[24]	Korrect G S, Minevich E A, Sivan B.High-grade transitional cell carcinoma of the pediatric bladder[J].J Pediatr Urol, 2012, 8(3):e36-e38.
[25]	Zhan X K, Zhang S, Cao B W, et al.Clinicopathological characteristics and treatment outcomes of Chinese patients with genitourinary embryonalrhabdomyosarcoma[J].World J Surg Oncol, 2015, 13:190.
[26]	Meyer W H, Spunt S L.Soft tissue sarcomas of childhood[J].Cancer Treat Rev, 2004, 30(3):269-280.
[27]	Seitz G, Dantonello T M, Int-Veen C, et al.Treatment efficiency, outcome and surgical treatment problems in patients suffering from localized embryonal bladder/prostate rhabdomyosarcoma:a report from the cooperative soft tissue sarcoma trial CWS-96[J].Pediatr Blood Cancer, 2011, 56(5):718-724.
[28]	Crist W M, Anderson J R, Meza J L, et al.Intergroup rhabdomyosarcoma study-IV:results for patients with nonmetastatic disease[J].J Clin Oncol, 2001, 19(12):3091-3102.
[29]	Breneman J C, Lyden E, Pappo A S, et al.Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma-a report from the Intergroup Rhabdomyosarcoma Study Ⅳ[J].J Clin Oncol, 2003, 21(1):78-84.
[30]	Slaoui H, Sanchez-Salas R, Validire P, et al.Urinary bladder leiomyosarcoma:Primary surgical treatment[J].Urol Case Rep, 2014, 2(4):137-138.
[31]	Menon A R, Puthalath R T, Suresh N, et al.Organ preservation in leiomyosarcoma bladder:Case report and review of literature[J].Urol Ann, 2018, 10(2):233-236.
[32]	Church E, Dieh A.A rare case of aggressive squamous cell carcinoma of the bladder in pregnancy[J].Obstet Med, 2013, 6(4):182-183.
[33]	Gleason J M, Bowlin P R, Bagli D J, et al.A comprehensive review of pediatric urachal anomalies and predictive analysis for adult urachal adenocarcinoma[J].J Urol, 2015, 193(2):632-636.
[34]	成波, 张爱民, 韩燕燕, 等.青年膀胱癌32例报告[J].肿瘤防治研究, 2010, 37(1):108-109.